Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pharmather Holdings Ltd
C.PHRM
Alternate Symbol(s):
PHRRF
psychedelics
PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The...
Company is also commercializing PharmaPatch (microneedle patch) with its partners to deliver psychedelics and drugs to treat infectious diseases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:PHRM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Apr 27, 2021 7:55am
PharmaTher Files Patent For Use Of Ketamine In Type 2 Diabet
PharmaTher Holdingshas expanded its patent portfolio. The company this morning announced the filing of a provisional patent application in the US for the novel use of ketamine as a potential treatment
...more
(36)
•••
GustheGreek
X
View Profile
View Bullboard History
Comment by
GustheGreek
on Apr 21, 2021 5:21pm
RE:PharmaTher Submits For Phase 2 Clinical Trial With FDA
Market cap should be 10X where it is right now. Give it a month or two and pop this goes, maybe sooner.
Pampa Metals Intersects 448 m @ 0.42% Cu, 0.46 g/t Au including 126m @ 0.66% Cu, 0.74 g/t Au
posted May 07, 2024 9:00am by
Pampa Metals Corp.
-
|
"Following on from the exceptional porphyry copper-gold intersections reported in the first hole of our maiden drill campaign at Piuquenes we are very pleased to report further long intervals of strong primary copper mineralization in the second hole. Our initial drilling continues to extend the depth and lateral extensions of mineralization at Piuquenes Central and has confirmed a highly mineralized multi-phase porphyry system ...read more
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Apr 20, 2021 7:38am
PharmaTher Submits For Phase 2 Clinical Trial With FDA
PharmaTher Holdings is looked to complete a phase two clinical trial. The company this morning announced the submittal of an investigational new drug application with the US FDA for its drug focused
...more
(12)
•••
mrgreen0
X
View Profile
View Bullboard History
Post by
mrgreen0
on Apr 16, 2021 9:44am
Cant trade shares?
Anyine else
(9)
•••
doysen
X
View Profile
View Bullboard History
Post by
doysen
on Mar 28, 2021 1:05pm
Phrm
Most undervalued psychedelics play crazy valuation
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Mar 24, 2021 7:19am
PharmaTher Sponsors Research For Novel Delivery Of Ketamine
PharmaTher this morning announced that it has entered into a sponsored research agreement. The agreement, which was signed with The Queen’s University of Belfast, will see the development of a
...more
(12)
•••
mrgreen0
X
View Profile
View Bullboard History
Post by
mrgreen0
on Mar 16, 2021 9:18pm
17 mil mcap
And phrm has 7 mil in cash .4 mil shares of revive therapeutic.phase 2 ketamine for few approval coming. Biotech company with low outstanding shares of 69mil.
(220)
•••
IceColdBeer
X
View Profile
View Bullboard History
Post by
IceColdBeer
on Mar 09, 2021 1:07pm
Is it time yet?
It's pretty quiet here.....hmmmmm
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Mar 02, 2021 8:07am
$PHRM - Update
https://stockhouse.com/news/press-releases/2021/03/02/pharmather-expands-to-neuromuscular-diseases-with-exclusive-license-agreement
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Feb 23, 2021 7:26am
PharmaTher Collaborates For Research On Psychedelic Microdos
PharmaTher this morning announced that it will be conducting further research related to psychedelics. The company this morning entered into a sponsored research agreement with that of the Terasaki
...more
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Feb 17, 2021 9:21am
$PHRM - Update ($$$$$)
https://stockhouse.com/news/press-releases/2021/02/17/pharmather-announces-sale-of-psilocybin-program
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Feb 04, 2021 9:43am
$PHRM - Update ($$$$$)
https://stockhouse.com/news/press-releases/2021/02/04/pharmather-announces-successful-completion-of-pre-ind-meeting-with-fda-for-the
(493)
•••
Iconic25
X
View Profile
View Bullboard History
Post by
Iconic25
on Feb 04, 2021 8:44am
Magic Mushrooms
Sponsored post: "Magic Mushrooms" have long, slender stems which may appear white or greyish topped by caps with dark gills on the underside. Read this to understand about magic muchrooms,
...more
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Feb 04, 2021 8:28am
PharmaTher To Commence Phase 2 Clinical Study On Ketamine In
Pharmather is successfully progressing on the development of its proposed phase 2 clinical study on ketamine in the use of levodopa-induced dyskinesia in patients with Parkinson’s disease. The company
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
NOI Filed for Drill Program at Lithium/Uranium Project in Nevada
Silvercorp to Acquire Adventus for Implied Consideration of C$0.50 per Share
Meet one of the Strongest Contenders to Lead Canada’s Cannabis Market
Multiple High-Grade Gold Hits at the Tonopah Gold Project Including 90 Meters at 2.0 gpt Gold
A Leading Provider in Virtual Healthcare Adds 4th Provincial Health Authority Contract